Stay updated with breaking news from Conjugated Antisense. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Donidalorsen delivered significant and sustained reductions in HAE attacks, with high levels of disease control and improvement in quality of life measures with monthly or every two-month dosing;...
Ionis Pharmaceuticals, Inc. (IONS.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Ionis Pharmaceuticals, Inc. | Nasdaq: IONS | Nasdaq
– Olezarsen met the primary endpoint with statistically significant reduction of fasting triglycerides and showed substantial, clinically meaningful reduction...
Significant improvement in steatohepatitis with
CARLSBAD, Calif., Feb. 8, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track designation to Ionis and AstraZeneca's...